Complexation hydrogels for intestinal delivery of interferon beta and calcitonin.

Recent studies have suggested that complexation hydrogels poly(methacrylic acid-g-ethylene glycol) (henceforth designated as P(MAA-g-EG)) exhibit high insulin incorporation efficiency, rapid insulin release in the intestine based on their pH-dependent complexation properties, enzyme-inhibiting effects and mucoadhesive characteristics. Therefore, they are promising carriers for insulin delivery via an oral route. As we designed these hydrogels as carriers suitable for oral administration of various peptide/protein drugs, in this study we aimed at investigating the applicability of P(MAA-g-EG) hydrogels to improving the intestinal absorption of various peptide/protein drugs. High loading efficiency into hydrogels was observed for insulin, calcitonin, and interferon beta. In addition, polymer microparticles loaded with calcitonin and interferon beta exhibited complexation/decomplexation and pH-sensitive release behavior. The molecular weight and chemical structure appeared to affect the efficiency of loading and release depending on the peptides and proteins. Furthermore, a drastic reduction of plasma calcium concentration accompanied by calcium absorption and a dose-dependent enhancement of plasma interferon beta concentration were observed after the administration of particles loaded with calcitonin or interferon beta into closed rat ileal segments. These findings indicate that P(MAA-g-EG) hydrogels are promising carriers for administration of various peptides and proteins via an oral route.

[1]  N. Peppas,et al.  Enhanced hydrogel adhesion by polymer interdiffusion: use of linear poly(ethylene glycol) as an adhesion promoter. , 1997, Journal of biomaterials science. Polymer edition.

[2]  Nicholas A Peppas,et al.  Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Kozo Takayama,et al.  Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats , 1992 .

[4]  N A Peppas,et al.  Devices based on intelligent biopolymers for oral protein delivery. , 2004, International journal of pharmaceutics.

[5]  Y. Kawashima,et al.  Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. , 2005, International journal of pharmaceutics.

[6]  Y. Kawashima,et al.  Enteral Absorption of Insulin in Rats from Mucoadhesive Chitosan-Coated Liposomes , 1996, Pharmaceutical Research.

[7]  M. Alonso,et al.  Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[8]  N. Peppas,et al.  Gastrointestinal transit and mucoadhesive characteristics of complexation hydrogels in rats. , 2006, Journal of pharmaceutical sciences.

[9]  H. Aboul‐Enein,et al.  The effect of oral absorption enhancers on the in vivo performance of insulin-loaded poly(ethylcyanoacrylate) nanospheres in diabetic rats , 2002, Journal of microencapsulation.

[10]  P. Caliceti,et al.  Design and In Vivo Evaluation of An Oral Delivery System for Insulin , 2000, Pharmaceutical Research.

[11]  N. Peppas,et al.  Investigation of the cytotoxicity and insulin transport of acrylic-based copolymer protein delivery systems in contact with Caco-2 cultures. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[12]  N. Peppas,et al.  Complexation hydrogels for oral insulin delivery: effects of polymer dosing on in vivo efficacy. , 2008, Journal of pharmaceutical sciences.

[13]  Y. Huang,et al.  Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[14]  N. Peppas Physiologically Responsive Hydrogels , 1991 .

[15]  P Couvreur,et al.  Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin. , 1997, Journal of pharmaceutical sciences.

[16]  N. Peppas,et al.  Complexation graft copolymer networks: swelling properties, calcium binding and proteolytic enzyme inhibition. , 1999, Biomaterials.

[17]  Nicholas A Peppas,et al.  Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[18]  M. Morishita,et al.  In Situ Ileal Absorption of Insulin in Rats: Effects of Hyaluronidase Pretreatment Diminishing the Mucous/Glycocalyx Layers , 2004, Pharmaceutical Research.

[19]  F. Plakogiannis,et al.  Enhanced oral absorption of insulin from desolvated fatty acid-sodium glycocholate emulsions , 1994 .

[20]  R. Tao,et al.  Oral administration of insulin as poly(vinyl alcohol)-gel spheres in diabetic rats. , 1996, Biological & pharmaceutical bulletin.

[21]  T. Park,et al.  Biodegradable nanoparticles containing protein-fatty acid complexes for oral delivery of salmon calcitonin. , 2004, Journal of pharmaceutical sciences.

[22]  N. Peppas,et al.  Oral delivery of insulin using pH-responsive complexation gels. , 1999, Journal of pharmaceutical sciences.

[23]  Kozo Takayama,et al.  Region-Dependent Role of the Mucous/Glycocalyx Layers in Insulin Permeation Across Rat Small Intestinal Membrane , 2005, Pharmaceutical Research.

[24]  Nicholas A Peppas,et al.  Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[25]  N. Peppas,et al.  Characterization of insulin protection properties of complexation hydrogels in gastric and intestinal enzyme fluids. , 2006, Journal of controlled release : official journal of the Controlled Release Society.